SCHEMBL7619938

SCHEMBL7619938

O=C(O)C(Cl)(Cl)CCCCCCCCc1ccc(Cc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
HDAC1 Q13547 5/20 0.46
FAAH O00519 3/20 0.46
CES1 P23141 3/20 0.46
LTB4R Q15722 2/20 0.46
TRPV1 Q8NER1 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
GRM2 Q14416 1/20 0.45
GRM3 Q14832 1/20 0.45
HDAC2 Q92769 2/20 0.44
ALOX5 P09917 1/20 0.44
HDAC3 O15379 1/20 0.43
MAPK1 P28482 1/20 0.43
ADRA1A P35348 1/20 0.43
HDAC4 P56524 1/20 0.43
SLC6A3 Q01959 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC10 Q969S8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7620024 0.94 MAPT (0.55) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL7620987 0.94 MAPT (0.55) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL7614749 0.94 MAPT (0.55) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL7620869 0.94 MAPT (0.55) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL7615234 0.94 MAPT (0.55) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL7614058 0.94 MAPT (0.55) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL9056155 0.90 S1PR2 (0.46) MAPTRXFP1HDAC1FAAHCES1
SCHEMBL7619429 0.85 FAAH (0.48) MAPTRXFP1FAAHCES1LTB4R
SCHEMBL682183 0.84 HDAC3 (0.49) HDAC1LTB4RHDAC2HDAC3HDAC4
SCHEMBL7615412 0.84 HDAC3 (0.49) HDAC1LTB4RHDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790824-B1 2,2-DICHLOROALKANE CARBOXYLIC ACIDS, PROCESS FOR PREPARING THE SAME, MEDICAMENT CONTAINING THE SAME, AND USE THEREOF FOR TREATING INSULIN RESISTANCE ROCHE DIAGNOSTICS GMBH (DE) 2002-02-06 EP disclosed
US-5968982-A TREATMENT OF DIABETES ROCHE DIAGNOSTICS GMBH (DE) 1999-10-19 US disclosed
EP-0790824-A1 2,2-DICHLOROALKANE CARBOXYLIC ACIDS, PROCESS FOR PREPARING THE SAME, MEDICAMENT CONTAINING THE SAME, AND USE THEREOF FOR TREATING INSULIN RESISTANCE Roche Diagnostics GmbH (DE) 1997-08-27 EP disclosed
WO-1996015784-A2 2,2-DICHLOROALKANE CARBOXYLIC ACIDS, PROCESS FOR PREPARING THE SAME, MEDICAMENT CONTAINING THE SAME, AND USE THEREOF FOR TREATING INSULIN RESISTANCE BOEHRINGER MANNHEIM GMBH (DE) 1996-05-30 WO disclosed